Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Christophersen

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Frontiers in Cellular and Infection Microbiology|April 29, 2021
Adjunctive S100A8/A9 Immunomodulation Hinders Ciprofloxacin Resistance in <i>Pseudomonas aeruginosa</i> in a Murine Biofilm Wound ModelAnne S Laulund, Franziska Schwartz, Hannah Trøstrup, et al.
Pathogens and Disease|May 23, 2019
Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound modelAnne Sofie Boe Laulund, Hannah Trøstrup, Christian Johann Lerche, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 13, 2021
Distinct contribution of hyperbaric oxygen therapy to human neutrophil function and antibiotic efficacy against Staphylococcus aureusFranziska A Schwartz, Christian J Lerche, Lars Christophersen, et al.
Biofilm|January 20, 2023
Hyperbaric oxygen therapy augments ciprofloxacin effect against <i>Pseudomonas aeruginosa</i> biofilm infected chronic wounds in a mouse modelAnne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 28, 2021
Novel human in vitro vegetation simulation model for infective endocarditisFranziska A Schwartz, Lars Christophersen, Anne Sofie Laulund, et al.
Journal of Global Antimicrobial Resistance|December 26, 2021
Lactoferricin-inspired peptide AMC-109 augments the effect of ciprofloxacin against Pseudomonas aeruginosa biofilm in chronic murine woundsAnne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, et al.
Microbiology (Reading, England)|June 30, 2007
Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection modelLouise D Christensen, Claus Moser, Peter Ø Jensen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 12, 2021
Animal models of chronic and recurrent Pseudomonas aeruginosa lung infection: significance of macrolide treatmentKim Thomsen, Osamu Kobayashi, Kenji Kishi, et al.
The Journal of Antimicrobial Chemotherapy|May 7, 2013
Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis modelJorunn Pauline Cavanagh, Hildegunn Norbakken Granslo, Elizabeth Aarag Fredheim, et al.
Frontiers in Microbiology|September 26, 2022
Chicken IgY reduces the risk of <i>Pseudomonas aeruginosa</i> urinary tract infections in a murine modelFranziska A Schwartz, Lars Christophersen, Kim Thomsen, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Frontiers in Cellular and Infection Microbiology|April 29, 2021
Adjunctive S100A8/A9 Immunomodulation Hinders Ciprofloxacin Resistance in <i>Pseudomonas aeruginosa</i> in a Murine Biofilm Wound ModelAnne S Laulund, Franziska Schwartz, Hannah Trøstrup, et al.
Pathogens and Disease|May 23, 2019
Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound modelAnne Sofie Boe Laulund, Hannah Trøstrup, Christian Johann Lerche, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 13, 2021
Distinct contribution of hyperbaric oxygen therapy to human neutrophil function and antibiotic efficacy against Staphylococcus aureusFranziska A Schwartz, Christian J Lerche, Lars Christophersen, et al.
Biofilm|January 20, 2023
Hyperbaric oxygen therapy augments ciprofloxacin effect against <i>Pseudomonas aeruginosa</i> biofilm infected chronic wounds in a mouse modelAnne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 28, 2021
Novel human in vitro vegetation simulation model for infective endocarditisFranziska A Schwartz, Lars Christophersen, Anne Sofie Laulund, et al.
Journal of Global Antimicrobial Resistance|December 26, 2021
Lactoferricin-inspired peptide AMC-109 augments the effect of ciprofloxacin against Pseudomonas aeruginosa biofilm in chronic murine woundsAnne Sofie Laulund, Franziska Angelika Schwartz, Lars Christophersen, et al.
Microbiology (Reading, England)|June 30, 2007
Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection modelLouise D Christensen, Claus Moser, Peter Ø Jensen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|June 12, 2021
Animal models of chronic and recurrent Pseudomonas aeruginosa lung infection: significance of macrolide treatmentKim Thomsen, Osamu Kobayashi, Kenji Kishi, et al.
The Journal of Antimicrobial Chemotherapy|May 7, 2013
Efficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis modelJorunn Pauline Cavanagh, Hildegunn Norbakken Granslo, Elizabeth Aarag Fredheim, et al.
Frontiers in Microbiology|September 26, 2022
Chicken IgY reduces the risk of <i>Pseudomonas aeruginosa</i> urinary tract infections in a murine modelFranziska A Schwartz, Lars Christophersen, Kim Thomsen, et al.
Pageof 3